Related Experiment Video

Updated: May 31, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Non-coding glucometers among pediatric patients with diabetes: looking for the target population and an accuracy

Wojciech Fendler1, Anna Hogendorf, Agnieszka Szadkowska

  • 1Department of Pediatrics, Oncology, Hematology, and Diabetology Medical University of Lodz, Poland. wojciech.mlynarski@joslin.havard.edu

Pediatric Endocrinology, Diabetes, and Metabolism
|July 5, 2011
PubMed

Insights

Coding errors in self-monitoring of blood glucose (SMBG) can be frequent, especially in pediatric diabetes care. The Contour TS non-coding glucometer offers accurate results, making it suitable for children with diabetes.

Area of Science:

  • Endocrinology
  • Medical Devices
  • Pediatric Diabetes Care

Background:

  • Self-monitoring of blood glucose (SMBG) is crucial for diabetes management.
  • Coding errors in glucometers pose a risk to accurate glucose readings.

Purpose of the Study:

  • Evaluate miscoding potential in personal glucometers.
  • Identify pediatric patients at risk for coding errors.
  • Assess the accuracy of the Contour TS non-coding glucometer.

Main Methods:

  • Anonymous questionnaire to assess miscoding likelihood.
  • Testing of Contour TS system per clinical laboratory standards.
  • Clarke error grid analysis for accuracy assessment.

Main Results:

  • Estimated miscoding prone individuals ranged from 7.95% to 68.21%.
  • Factors increasing miscoding risk include fewer tests/day and multiple users.
  • Contour TS demonstrated high accuracy (R2=0.99) with minimal bias (-1.12%).

Conclusions:

  • The Contour TS system is accurate and safe for pediatric diabetes monitoring.
  • Patients at high risk for coding errors benefit from non-coding glucometers like Contour TS.
Abstract

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Simple Continuous Glucose Monitoring in Freely Moving Mice03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...